Article Abstract

Canagliflozin lowers blood sugar, but does it also lower cardiovascular risk? Maybe not

Authors: Thomas F. Heston, Anndres H. Olson, Nicholas R. Randall


For the last 25 years it has been widely accepted that diabetes mellitus is associated with a twofold or greater risk of clinical atherosclerotic disease (1). Long-standing elevated blood sugar levels, as measured by the hemoglobin A1c level, have been shown to be independent of major cardiovascular risk factors including age, body mass index, systolic blood pressure, serum cholesterol, cigarette smoking, or history of cardiovascular disease (2).